IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

DC Funds, LP

Q4 2024 Holdings

Filed 2025-02-14 | 3 holdings | $3.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tscan Therapeutics Inc(TCRX)COM89854M101$1.9M630,00053.8%
Werewolf Therapeutics Inc(HOWL)COM95075A107$871.9K589,10224.5%
Barinthus Biotherapeutics PL(BRNS)ADS91864C107$775.8K642,20421.8%